{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T23:21:33Z","timestamp":1785280893750,"version":"3.55.0"},"reference-count":43,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2022,10,4]],"date-time":"2022-10-04T00:00:00Z","timestamp":1664841600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"State University of New York startup funding","award":["#910252-50"],"award-info":[{"award-number":["#910252-50"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Ring1 and YY1 Binding Protein (RYBP) is a member of the non-canonical polycomb repressive complex 1 (PRC1), and like other PRC1 members, it is best described as a transcriptional regulator. Previously, we showed that RYBP, along with other PRC1 members, is also involved in the DNA damage response. RYBP inhibits recruitment of breast cancer gene 1(BRCA1) complex to DNA damage sites through its binding to K63-linked ubiquitin chains. In addition, ataxia telangiectasia mutated (ATM) kinase serves as an important sensor kinase in early stages of DNA damage response. Here, we report that overexpression of RYBP results in inhibition in both ATM activity and recruitment to DNA damage sites. Cells expressing RYBP show less phosphorylation of the ATM substrate, Chk2, after DNA damage. Due to its ability to inhibit ATM activity, we find that RYBP sensitizes cancer cells to poly-ADP-ribose polymerase (PARP) inhibitors. Although we find a synergistic effect between PARP inhibitor and ATM inhibitor in cancer cells, this synergy is lost in cells expressing RYBP. We also show that overexpression of RYBP hinders cancer cell migration through, at least in part, ATM inhibition. We provide new mechanism(s) by which RYBP expression may sensitize cancer cells to DNA damaging agents and inhibits cancer metastasis.<\/jats:p>","DOI":"10.3390\/ijms231911764","type":"journal-article","created":{"date-parts":[[2022,10,8]],"date-time":"2022-10-08T23:39:31Z","timestamp":1665272371000},"page":"11764","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["RYBP Sensitizes Cancer Cells to PARP Inhibitors by Regulating ATM Activity"],"prefix":"10.3390","volume":"23","author":[{"given":"Deanna V.","family":"Maybee","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Sciences, SUNY Binghamton University School of Pharmacy and Pharmaceutical Sciences, Binghamton, NY 13790, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4978-6003","authenticated-orcid":false,"given":"Alexandra Maria","family":"Psaras","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, SUNY Binghamton University School of Pharmacy and Pharmaceutical Sciences, Binghamton, NY 13790, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy A.","family":"Brooks","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, SUNY Binghamton University School of Pharmacy and Pharmaceutical Sciences, Binghamton, NY 13790, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6404-4198","authenticated-orcid":false,"given":"Mohammad A. M.","family":"Ali","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, SUNY Binghamton University School of Pharmacy and Pharmaceutical Sciences, Binghamton, NY 13790, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,10,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"10389","DOI":"10.1073\/pnas.190030497","article-title":"Ataxia Telangiectasia-Mutated Phosphorylates Chk2 in Vivo and in Vitro","volume":"97","author":"Matsuoka","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.celrep.2017.12.047","article-title":"RYBP Is a K63-Ubiquitin-Chain-Binding Protein That Inhibits Homologous Recombination Repair","volume":"22","author":"Ali","year":"2018","journal-title":"Cell Rep."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.1038\/onc.2013.275","article-title":"ATM Signalling and Cancer","volume":"33","author":"Cremona","year":"2014","journal-title":"Oncogene"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Jette, N.R., Kumar, M., Radhamani, S., Arthur, G., Goutam, S., Yip, S., Kolinsky, M., Williams, G.J., Bose, P., and Lees-Miller, S.P. (2020). ATM-Deficient Cancers Provide New Opportunities for Precision Oncology. Cancers, 12.","DOI":"10.3390\/cancers12030687"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1158\/0008-5472.CAN-16-3398","article-title":"ATM Deficiency Is Associated with Sensitivity to PARP1- and ATR Inhibitors in Lung Adenocarcinoma","volume":"77","author":"Schmitt","year":"2017","journal-title":"Cancer Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.cellsig.2016.10.011","article-title":"Tumor Suppressor RYBP Harbors Three Nuclear Localization Signals and Its Cytoplasm-Located Mutant Exerts More Potent Anti-Cancer Activities than Corresponding Wild Type","volume":"29","author":"Tan","year":"2017","journal-title":"Cell Signal."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1111\/jcmm.13503","article-title":"Multiple Roles of Ring 1 and YY1 Binding Protein in Physiology and Disease","volume":"22","author":"Zhan","year":"2018","journal-title":"J. Cell. Mol. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/s41556-020-0484-1","article-title":"RYBP\/YAF2-PRC1 Complexes and Histone H1-Dependent Chromatin Compaction Mediate Propagation of H2AK119ub1 during Cell Division","volume":"22","author":"Zhao","year":"2020","journal-title":"Nat. Cell Biol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"11604","DOI":"10.18632\/oncotarget.2598","article-title":"RYBP Expression Is Associated with Better Survival of Patients with Hepatocellular Carcinoma (HCC) and Responsiveness to Chemotherapy of HCC Cells in vitro and in vivo","volume":"5","author":"Wang","year":"2014","journal-title":"Oncotarget"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"7691","DOI":"10.1038\/sj.onc.1207986","article-title":"Activation of ATM and Chk2 Kinases in Relation to the Amount of DNA Strand Breaks","volume":"23","author":"Buscemi","year":"2004","journal-title":"Oncogene"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1200\/JCO.2007.14.6613","article-title":"Risk of Cancer by ATM Missense Mutations in the General Population","volume":"26","author":"Dombernowsky","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.canlet.2009.12.001","article-title":"ATM- and ATR-Mediated Response to DNA Damage Induced by a Novel Camptothecin, ST1968","volume":"292","author":"Zuco","year":"2010","journal-title":"Cancer Lett."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"9107","DOI":"10.1074\/jbc.M110.204065","article-title":"Autophosphorylation and ATM Activation","volume":"286","author":"Kozlov","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"21744","DOI":"10.18632\/oncotarget.24934","article-title":"Camptothecin Induces G2\/M Phase Arrest through the ATM-Chk2-Cdc25C Axis as a Result of Autophagy-Induced Cytoprotection: Implications of Reactive Oxygen Species","volume":"9","author":"Dilshara","year":"2018","journal-title":"Oncotarget"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Moslemi, M., Moradi, Y., Dehghanbanadaki, H., Afkhami, H., Khaledi, M., Sedighimehr, N., Fathi, J., and Sohrabi, E. (2021). The Association between ATM Variants and Risk of Breast Cancer: A Systematic Review and Meta-Analysis. BMC Cancer, 21.","DOI":"10.1186\/s12885-020-07749-6"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"23257","DOI":"10.1038\/s41598-021-02719-9","article-title":"DNA Repair Inhibitors Sensitize Cells Differently to High and Low LET Radiation","volume":"11","author":"Bannik","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"107391","DOI":"10.1016\/j.pharmthera.2019.07.002","article-title":"ATM in DNA Repair in Cancer","volume":"203","author":"Jin","year":"2019","journal-title":"Pharmcol. Ther."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"8109","DOI":"10.1158\/0008-5472.CAN-06-0140","article-title":"Deficiency in the Repair of DNA Damage by Homologous Recombination and Sensitivity to Poly(ADP-Ribose) Polymerase Inhibition","volume":"66","author":"McCabe","year":"2006","journal-title":"Cancer Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13046-018-0772-9","article-title":"The PARP Inhibitor Olaparib Potentiates the Effect of the DNA Damaging Agent Doxorubicin in Osteosarcoma","volume":"37","author":"Park","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"4578","DOI":"10.1182\/blood-2010-01-265769","article-title":"The PARP Inhibitor Olaparib Induces Significant Killing of ATM-Deficient Lymphoid Tumor Cells in vitro and in vivo","volume":"116","author":"Weston","year":"2010","journal-title":"Blood"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1056\/NEJMoa1903387","article-title":"Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer","volume":"381","author":"Golan","year":"2019","journal-title":"New Engl. J. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s40164-019-0154-9","article-title":"Advances and Perspectives of PARP Inhibitors","volume":"8","author":"Yi","year":"2019","journal-title":"Exp. Hematol. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/1756-9966-32-95","article-title":"ATM-Depletion in Breast Cancer Cells Confers Sensitivity to PARP Inhibition","volume":"32","author":"Prodosmo","year":"2013","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1146\/annurev-biochem-060614-034335","article-title":"Mechanisms of ATM Activation","volume":"84","author":"Paull","year":"2015","journal-title":"Annu. Rev. Biochem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/cyto.a.22327","article-title":"Relationship between DNA Damage Response, Initiated by Camptothecin or Oxidative Stress, and DNA Replication, Analyzed by Quantitative 3D Image Analysis","volume":"83","author":"Berniak","year":"2013","journal-title":"Cytom. Part A"},{"key":"ref_26","first-page":"632","article-title":"Studies on Camptothecin. I. Effects on Nucleic Acid and Protein Synthesis","volume":"7","author":"Horwitz","year":"1971","journal-title":"Mol. Pharm."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"25920","DOI":"10.18632\/aging.203780","article-title":"LDH-A Inhibitors as Remedies to Enhance the Anticancer Effects of PARP Inhibitors in Ovarian Cancer Cells","volume":"13","author":"Xiang","year":"2021","journal-title":"Aging"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e072720","DOI":"10.7554\/eLife.07270","article-title":"ATM Regulation of IL-8 Links Oxidative Stress to Cancer Cell Migration and Invasion","volume":"4","author":"Chen","year":"2015","journal-title":"Elife"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.1038\/sj.emboj.7601231","article-title":"Involvement of Novel Autophosphorylation Sites in ATM Activation","volume":"25","author":"Kozlov","year":"2006","journal-title":"EMBO J."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"7741","DOI":"10.1038\/sj.onc.1210872","article-title":"Activation and Regulation of ATM Kinase Activity in Response to DNA Double-Strand Breaks","volume":"26","author":"Lee","year":"2007","journal-title":"Oncogene"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"5576","DOI":"10.1158\/0008-5472.CAN-17-0634","article-title":"ATM Deficiency Generating Genomic Instability Sensitizes Pancreatic Ductal Adenocarcinoma Cells to Therapy-Induced DNA Damage","volume":"77","author":"Perkhofer","year":"2017","journal-title":"Cancer Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"12638","DOI":"10.1128\/JVI.05009-11","article-title":"DNA Damage Response Signaling Triggers Nuclear Localization of the Chicken Anemia Virus Protein Apoptin","volume":"85","author":"Kucharski","year":"2011","journal-title":"J. Virol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/sj.cdd.4401391","article-title":"Human Death Effector Domain-Associated Factor Interacts with the Viral Apoptosis Agonist Apoptin and Exerts Tumor-Preferential Cell Killing","volume":"11","author":"Voskamp","year":"2004","journal-title":"Cell Death Differ."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"7832","DOI":"10.1128\/MCB.00534-06","article-title":"DNA Damage-Induced Cell Cycle Regulation and Function of Novel Chk2 Phosphoresidues","volume":"26","author":"Buscemi","year":"2006","journal-title":"Mol. Cell Biol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"4419","DOI":"10.1128\/MCB.22.12.4419-4432.2002","article-title":"Chk2 Activation and Phosphorylation-Dependent Oligomerization","volume":"22","author":"Xu","year":"2002","journal-title":"Mol. Cell Biol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13048-019-0532-2","article-title":"MiR-203a-3p Regulates the Biological Behaviors of Ovarian Cancer Cells through Mediating the Akt\/GSK-3\u03b2\/Snail Signaling Pathway by Targeting ATM","volume":"12","author":"Liu","year":"2019","journal-title":"J. Ovarian Res."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Aguilar-Quesada, R., Mu\u00f1oz-G\u00e1mez, J.A., Mart\u00edn-Oliva, D., Peralta, A., Valenzuela, M.T., Mat\u00ednez-Romero, R., Quiles-P\u00e9rez, R., Murcia, J.M., de Murcia, G., and de Almod\u00f3var, M.R. (2007). Interaction between ATM and PARP-1 in Response to DNA Damage and Sensitization of ATM Deficient Cells through PARP Inhibition. BMC Mol. Biol., 8.","DOI":"10.1186\/1471-2199-8-29"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.tranon.2017.01.007","article-title":"ATM-Deficient Colorectal Cancer Cells Are Sensitive to the PARP Inhibitor Olaparib","volume":"10","author":"Wang","year":"2017","journal-title":"Transl. Oncol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"4869","DOI":"10.1038\/s41388-020-1328-y","article-title":"Combined PARP and ATR Inhibition Potentiates Genome Instability and Cell Death in ATM-Deficient Cancer Cells","volume":"39","author":"Lloyd","year":"2020","journal-title":"Oncogene"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"839508","DOI":"10.3389\/fonc.2022.839508","article-title":"Blocking ATM Attenuates SKOV3 Cell Proliferation and Migration by Disturbing OGT\/OGA Expression via Hsa-MiR-542-5p","volume":"12","author":"Wang","year":"2022","journal-title":"Front. Oncol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1158\/1535-7163.MCT-09-0519","article-title":"Improved ATM Kinase Inhibitor KU-60019 Radiosensitizes Glioma Cells, Compromises Insulin, AKT and ERK Prosurvival Signaling, and Inhibits Migration and Invasion","volume":"8","author":"Golding","year":"2009","journal-title":"Mol. Cancer Ther."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.tranon.2017.01.004","article-title":"RYBP Inhibits Progression and Metastasis of Lung Cancer by Suppressing EGFR Signaling and Epithelial-Mesenchymal Transition","volume":"10","author":"Dinglin","year":"2017","journal-title":"Transl. Oncol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.3892\/ijo.2016.3718","article-title":"RING1 and YY1 Binding Protein Suppresses Breast Cancer Growth and Metastasis","volume":"49","author":"Zhou","year":"2016","journal-title":"Int. J. Oncol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/19\/11764\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:46:21Z","timestamp":1760143581000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/19\/11764"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,4]]},"references-count":43,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2022,10]]}},"alternative-id":["ijms231911764"],"URL":"https:\/\/doi.org\/10.3390\/ijms231911764","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,4]]}}}